The administration of four-factor prothrombin complex concentrate exacerbates thrombin generation in trauma patients at risk of massive transfusion: an ancillary study of the PROCOAG trial

被引：2
|
作者：
Greze, Jules [1 ]
Marlu, Raphael [2 ]
Baud, Mariette [1 ]
Seyve, Landry [3 ]
Gauss, Tobias [1 ]
Bouzat, Pierre [1 ,4 ]
机构：
[1] Univ Grenoble Alpes, Grenoble Inst Neurosci, Inserm, U1216,CHU Grenoble Alpes, F-38000 Grenoble, France
[2] Univ Grenoble Alpes, Hemostasis Lab, CNRS TIMC UMR5525, CHU Grenoble Alpes, F-38000 Grenoble, France
[3] CHU Grenoble Alpes, Hemostasis Lab, F-38000 Grenoble, France
[4] Hop Albert Michallon, Pole Anesthesie Reanimat, BP 217, F-38043 Grenoble, France
来源：
CRITICAL CARE | 2024年 / 28卷 / 01期
关键词：
D O I：
10.1186/s13054-024-04836-z
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] USE OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE IN PATIENTS WITH LIVER DISEASE
    Larson, Jared
    Coler, Emily
    Vakayil, Victor
    Chandrashekar, Malavika
    Lord, Amanda
    Zantek, Nicole
    Harmon, James
    CRITICAL CARE MEDICINE, 2018, 46 (01) : 243 - 243
  • [22] The role of four-factor prothrombin complex concentrate in coagulopathy of trauma: A propensity matched analysis
    Jehan, Faisal
    Aziz, Hassan
    O'Keeffe, Terence
    Khan, Muhammad
    Zakaria, El Rasheid
    Hamidi, Mohammad
    Zeeshan, Muhammad
    Kulvatunyou, Narong
    Joseph, Bellal
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2018, 85 (01): : 18 - 24
  • [23] Four-Factor Prothrombin Complex Concentrate for Coagulopathy Reversal in Patients With Liver Disease
    Huang, Wan-Ting
    Cang, William C.
    Derry, Katrina L.
    Lane, James R.
    von Drygalski, Annette
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2017, 23 (08) : 1028 - 1035
  • [24] FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE IN ANTICOAGULATION-NAIVE CARDIOTHORACIC SURGERY PATIENTS
    Bundy, Angela
    Dwivedi, Ruti
    Ventura, Davide
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [25] The use of four-factor prothrombin complex concentrate in patients with liver disease on warfarin therapy
    Stevens, Craig A.
    Yau, Benny C.
    Lai, Ngan C.
    Huang, Wan-Ting
    Cang, William C.
    Bushway, Audrey
    Derry, Katrina L.
    THROMBOSIS RESEARCH, 2021, 204 : 123 - 125
  • [26] Clinical utilization of four-factor prothrombin complex concentrate: a retrospective single center study
    Naeem, Zaina
    Allan, Salsabeel
    Hernandez, Aneury
    Galanakis, Dennis K.
    Singer, Adam J.
    CLINICAL AND EXPERIMENTAL EMERGENCY MEDICINE, 2021, 8 (02): : 75 - 81
  • [27] Four-factor Prothrombin Complex Concentrate During Liver Transplantation: A Retrospective Cohort Study
    Lee, Jennifer
    Rivero, Andrea
    Renew, J. Ross
    Spaulding, Aaron
    Borkar, Shalmali
    McKenzie, Ian
    Davey, Kuki
    Ladlie, Beth
    TRANSPLANTATION DIRECT, 2024, 10 (06):
  • [28] PROTHROMBIN TIME IS NOT ASSOCIATED WITH THROMBIN GENERATION AFTER PROTHROMBIN COMPLEX CONCENTRATE ADMINISTRATION IN PATIENTS WITH INTRACRANIAL HEMORRHAGE
    Voils, Stacy A.
    Martin, Erika J.
    Bayrlee, Ahmad
    Brophy, Donald F.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E75 - E76
  • [29] The Use of Four-Factor Prothrombin Complex Concentrate versus Fresh Frozen Plasma in Patients With Cirrhosis
    Mandel, Julie
    Ahmad, Samrah
    Lee, Susan
    Bernstein, David
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S626 - S626
  • [30] Four-factor prothrombin complex concentrate administration after expanding intracranial hemorrhage status post administration of andexanet alfa
    Blackburn, Matthew
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 62 : 144.e1 - 144.e3
12345